Vor Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vor Biopharma and other ETFs, options, and stocks.About VOR
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies.
CEOJean-Paul Kress
CEOJean-Paul Kress
Employees159
Employees159
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2015
Founded2015
Employees159
Employees159
VOR Key Statistics
Market cap333.80M
Market cap333.80M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume6.54M
Average volume6.54M
High today$13.90
High today$13.90
Low today$13.00
Low today$13.00
Open price$13.50
Open price$13.50
Volume567.48K
Volume567.48K
52 Week high$65.80
52 Week high$65.80
52 Week low$2.62
52 Week low$2.62
Stock Snapshot
The current Vor Biopharma(VOR) stock price is $13.79, with a market capitalization of 333.8M. The stock trades at a price-to-earnings (P/E) ratio of -0.04.
As of 2025-12-23, Vor Biopharma(VOR) stock has fluctuated between $13.00 and $13.90. The current price stands at $13.79, placing the stock +6.1% above today's low and -0.8% off the high.
Vor Biopharma(VOR) shares are trading with a volume of 567.48K, against a daily average of 6.54M.
In the last year, Vor Biopharma(VOR) shares hit a 52-week high of $65.80 and a 52-week low of $2.62.
In the last year, Vor Biopharma(VOR) shares hit a 52-week high of $65.80 and a 52-week low of $2.62.
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own VOR. This list is generated using Robinhood data, and it’s not a recommendation.